Label Set for an Inhalation Device
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 29/469,595, filed Oct 11, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US D768,241 | Label Set for an Inhalation Device In force · High confidence | Glaxo Group Limited | In force | High confidence | ||
| US D841,740 | Label Set for an Inhalation Device In force · High confidence | Glaxo Group Limited | In force | High confidence | ||
| US D938,521 | Label Set for an Inhalation Device In force · High confidence | Glaxo Group Limited | In force | High confidence | ||
| US D1,104,149 | Label Set for an Inhalation Device In force · High confidence | Glaxo Group Limited | In force | High confidence | ||
| Application 29/469,595 | Label Set for an Inhalation Device Abandoned Abandoned Oct 19, 2015 | Glaxo Group Limited | Abandoned | Abandoned Oct 19, 2015 |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Glaxo Group Limited.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.